Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01772173 · ClinicalTrials.gov registry record
Retinal Vessel Measurements as Clinically Useful Predictors in Veterans
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 800
- Enrollment target
NCT01772173: Completed study, sponsored by VA Office of Research and Development.
NCT01772173 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01772173 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 800 participants
- Enrollment target
Study Summary
Diabetic complications are an important source of blindness and mortality among Veterans. Their occurrence is unpredictable because of the highly variable effect of factors such as weight, diet and exercise. Improved prediction of diabetes complications has the potential to improve the care for Veterans with diabetes, especially if this can be done without any extra effort for the Veterans or their caretakers. All Veterans with diabetes in VHA are required to undergo annual retinal photography to screen for current diabetic retinopathy. The investigators have recently developed an automated, precise, fast, novel tool for measuring retinal vessels in these images. Manual measurement of retinal vessels has shown that these can predict future -not current- development of hypertension and also diabetic retinopathy. If the investigators can confirm that their tool can flag those Veterans at increased risk for developing these diabetes complications, this will allow earlier intervention and prevention. Because the tool only uses the images that are being taken anyway, there is no extra effort for either the Veteran or VA staff.
Primary Outcome
AUC of automatically derived retinal vessel parameters (arterial and retinal vessel width and branch relationships) as an early biomarker for future development of hypertension no less than 2 years later, with normal current normal blood pressure.
Interventions
- OTHER Vessel measurements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2013-02-01 |
| Est. Completion | 2017-03-01 |
What the finished NCT01772173 record still lists
NCT01772173 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Vessel measurements is the first listed.
NCT01772173 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01772173 about?
NCT01772173 is a clinical study titled "Retinal Vessel Measurements as Clinically Useful Predictors in Veterans". Diabetic complications are an important source of blindness and mortality among Veterans. Their occurrence is unpredictable because of the highly variable effect of factors such as weight, diet and exercise. Improved prediction of diabetes complications has the potential to improve the care for Vete...
What is the current status of trial NCT01772173?
This trial is currently completed. The enrollment target is 800 participants. The study started on 2013-02-01. Estimated completion is 2017-03-01.
What interventions are being tested in trial NCT01772173?
The interventions under investigation include: Vessel measurements (OTHER).
Who is sponsoring clinical trial NCT01772173?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI